Fomina Ds 1
1. Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021
2. GATA2 deficiency: a long way to diagnosis (case report)
3. One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis
4. Analysis of the sensitization spectrum in patients with severe allergic diseases using the ImmunoCAP ISAC method
5. Artificial intelligence tools for molecular analysis of sensitization profiles in patients with atopic dermatitis and bronchial asthma
6. ASIA syndrome masked as recurrent angioedema: сan development be predicted by genetic screening (pilot study)
7. Efficacy of benralizumab in severe eosinophilic asthma: an interim analysis of a real clinical practice prospective study BEST in Russia
8. Efficacy of benralizumab in severe eosinophilic asthma: results of a real clinical practice prospective study BEST in Russia
9. Efficacy of olokizumab in patients with mild or moderate COVID-19 and risk factors of progression moderate
10. Myoferline gene mutation сan be associated with recurrent angioedema
11. Safety of sipavibart as a pre-exposure prophylaxis for COVID-19 in individuals at high risk of developing severe disease: results of the NOVELLA clinical study conducted in the Russian population
12. Treatment of atopic dermatitis with upadacitinib: adcare single center experience
13. Vasculitis with nervous system damage in a patient with adenosine deaminase 2 deficiency
14. Urticaria
15. Analysis of patients with cold urticaria in the context of typical and atypical forms
16. Recurrent angioedema with normal C1-inhibitor: genetics determine the endotype
17. Artificial intelligence tools for phenotyping patients with anaphylaxis
18. Clinical-anamnestic analysis of patients diagnosed as Anaphylaxis hospitalized in Moscow medical hospitals
19. Clinical and anamnestic analysis of patients with Stevens–Johnson syndrome/toxic epidermal necrolysis hospitalised in Moscow. Development of a prognostic model of unfavourable outcomes
20. Clinical and morphological characteristics of patients with urticarian rasches
21. New coronavirus infection SARS-CoV-2 in adult patients with inborn errors of immunity
22. Still’s disease in a patient with common variable immunodeficiency: NFKB1 defect
23. Comparative analysis of clinical efficacy and safety of omalizumab biosimilar in the treatment of patients with chronic spontaneous urticaria
1